• レポートコード:QYR2104Z4098 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、131ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療機器 |
Single User | ¥553,800 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥830,700 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、神経リハビリテーション装置のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(植込み型神経リハビリテーションシステム、ニューロロボティクスシステム、ブレインコンピューターインターフェース、非侵襲的刺激装置、その他)、用途別市場規模(病院、診療所、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・神経リハビリテーション装置の市場動向 ・企業の競争状況、市場シェア ・神経リハビリテーション装置の種類別市場規模(植込み型神経リハビリテーションシステム、ニューロロボティクスシステム、ブレインコンピューターインターフェース、非侵襲的刺激装置、その他) ・神経リハビリテーション装置の用途別市場規模(病院、診療所、その他) ・神経リハビリテーション装置の北米市場規模2016-2027(アメリカ、カナダ) ・神経リハビリテーション装置のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・神経リハビリテーション装置のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・神経リハビリテーション装置の中南米市場規模2016-2027(メキシコ、ブラジル) ・神経リハビリテーション装置の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Medtronic、Abbott Laboratories、Boston Scientific、Bioness、Hocoma AG、Neuronetics、Yiruide、Magstim、VISHEE、Ekso Bionics、Alter G、MagVenture、Tyromotion、Soterix Medical、Neuroelectrics、Bionik Laboratories、Helius Medical) ・結論 |
Neurorehabilitation devices helps to improve function, reduce symptoms and improve the wellbeing of people with diseases such as trauma or disorders of the nervous system. Infections, tumours, disorders, degenerative diseases, injuries and structural defects in the circulatory system can impair the nervous system.
North America is the largest consumption place for Neurorehabilitation devices, with a consumption market share over 40%, followed by Europe. Medtronic, Abbott, Boston Scientific, Bioness and Hocoma AG are the major manufacturers in this industry, with Medtronic having the largest market share, exceeding 30%. The classification of Neurorehabilitation devices includes Implantable Neurorehabilitation System, Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, etc. They have been widely used in hospitals and clinics
Market Analysis and Insights: Global Neurorehabilitation Devices Market
The global Neurorehabilitation Devices market size is projected to reach US$ 2154.4 million by 2026, from US$ 1142.8 million in 2019, at a CAGR of 12.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neurorehabilitation Devices market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neurorehabilitation Devices market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neurorehabilitation Devices market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neurorehabilitation Devices market.
Global Neurorehabilitation Devices Scope and Market Size
Neurorehabilitation Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurorehabilitation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Implantable Neurorehabilitation System
Neurorobotic System
Brain Computer Interface
Non-invasive Stimulators
Other
Segment by Application
Hospitals
Clinics
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma AG
Neuronetics
Yiruide
Magstim
VISHEE
Bioness
Hocoma AG
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurorehabilitation Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Implantable Neurorehabilitation System
1.2.3 Neurorobotic System
1.2.4 Brain Computer Interface
1.2.5 Non-invasive Stimulators
1.2.6 Other
1.3 Market by Application
1.3.1 Global Neurorehabilitation Devices Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neurorehabilitation Devices Market Perspective (2016-2027)
2.2 Neurorehabilitation Devices Growth Trends by Regions
2.2.1 Neurorehabilitation Devices Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neurorehabilitation Devices Historic Market Share by Regions (2016-2021)
2.2.3 Neurorehabilitation Devices Forecasted Market Size by Regions (2022-2027)
2.3 Neurorehabilitation Devices Industry Dynamic
2.3.1 Neurorehabilitation Devices Market Trends
2.3.2 Neurorehabilitation Devices Market Drivers
2.3.3 Neurorehabilitation Devices Market Challenges
2.3.4 Neurorehabilitation Devices Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurorehabilitation Devices Players by Revenue
3.1.1 Global Top Neurorehabilitation Devices Players by Revenue (2016-2021)
3.1.2 Global Neurorehabilitation Devices Revenue Market Share by Players (2016-2021)
3.2 Global Neurorehabilitation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neurorehabilitation Devices Revenue
3.4 Global Neurorehabilitation Devices Market Concentration Ratio
3.4.1 Global Neurorehabilitation Devices Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurorehabilitation Devices Revenue in 2020
3.5 Neurorehabilitation Devices Key Players Head office and Area Served
3.6 Key Players Neurorehabilitation Devices Product Solution and Service
3.7 Date of Enter into Neurorehabilitation Devices Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurorehabilitation Devices Breakdown Data by Type
4.1 Global Neurorehabilitation Devices Historic Market Size by Type (2016-2021)
4.2 Global Neurorehabilitation Devices Forecasted Market Size by Type (2022-2027)
5 Neurorehabilitation Devices Breakdown Data by Application
5.1 Global Neurorehabilitation Devices Historic Market Size by Application (2016-2021)
5.2 Global Neurorehabilitation Devices Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neurorehabilitation Devices Market Size (2016-2027)
6.2 North America Neurorehabilitation Devices Market Size by Type
6.2.1 North America Neurorehabilitation Devices Market Size by Type (2016-2021)
6.2.2 North America Neurorehabilitation Devices Market Size by Type (2022-2027)
6.2.3 North America Neurorehabilitation Devices Market Size by Type (2016-2027)
6.3 North America Neurorehabilitation Devices Market Size by Application
6.3.1 North America Neurorehabilitation Devices Market Size by Application (2016-2021)
6.3.2 North America Neurorehabilitation Devices Market Size by Application (2022-2027)
6.3.3 North America Neurorehabilitation Devices Market Size by Application (2016-2027)
6.4 North America Neurorehabilitation Devices Market Size by Country
6.4.1 North America Neurorehabilitation Devices Market Size by Country (2016-2021)
6.4.2 North America Neurorehabilitation Devices Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Neurorehabilitation Devices Market Size (2016-2027)
7.2 Europe Neurorehabilitation Devices Market Size by Type
7.2.1 Europe Neurorehabilitation Devices Market Size by Type (2016-2021)
7.2.2 Europe Neurorehabilitation Devices Market Size by Type (2022-2027)
7.2.3 Europe Neurorehabilitation Devices Market Size by Type (2016-2027)
7.3 Europe Neurorehabilitation Devices Market Size by Application
7.3.1 Europe Neurorehabilitation Devices Market Size by Application (2016-2021)
7.3.2 Europe Neurorehabilitation Devices Market Size by Application (2022-2027)
7.3.3 Europe Neurorehabilitation Devices Market Size by Application (2016-2027)
7.4 Europe Neurorehabilitation Devices Market Size by Country
7.4.1 Europe Neurorehabilitation Devices Market Size by Country (2016-2021)
7.4.2 Europe Neurorehabilitation Devices Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neurorehabilitation Devices Market Size (2016-2027)
8.2 Asia-Pacific Neurorehabilitation Devices Market Size by Type
8.2.1 Asia-Pacific Neurorehabilitation Devices Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neurorehabilitation Devices Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neurorehabilitation Devices Market Size by Type (2016-2027)
8.3 Asia-Pacific Neurorehabilitation Devices Market Size by Application
8.3.1 Asia-Pacific Neurorehabilitation Devices Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neurorehabilitation Devices Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neurorehabilitation Devices Market Size by Application (2016-2027)
8.4 Asia-Pacific Neurorehabilitation Devices Market Size by Region
8.4.1 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neurorehabilitation Devices Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neurorehabilitation Devices Market Size (2016-2027)
9.2 Latin America Neurorehabilitation Devices Market Size by Type
9.2.1 Latin America Neurorehabilitation Devices Market Size by Type (2016-2021)
9.2.2 Latin America Neurorehabilitation Devices Market Size by Type (2022-2027)
9.2.3 Latin America Neurorehabilitation Devices Market Size by Type (2016-2027)
9.3 Latin America Neurorehabilitation Devices Market Size by Application
9.3.1 Latin America Neurorehabilitation Devices Market Size by Application (2016-2021)
9.3.2 Latin America Neurorehabilitation Devices Market Size by Application (2022-2027)
9.3.3 Latin America Neurorehabilitation Devices Market Size by Application (2016-2027)
9.4 Latin America Neurorehabilitation Devices Market Size by Country
9.4.1 Latin America Neurorehabilitation Devices Market Size by Country (2016-2021)
9.4.2 Latin America Neurorehabilitation Devices Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurorehabilitation Devices Market Size (2016-2027)
10.2 Middle East & Africa Neurorehabilitation Devices Market Size by Type
10.2.1 Middle East & Africa Neurorehabilitation Devices Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neurorehabilitation Devices Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neurorehabilitation Devices Market Size by Type (2016-2027)
10.3 Middle East & Africa Neurorehabilitation Devices Market Size by Application
10.3.1 Middle East & Africa Neurorehabilitation Devices Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neurorehabilitation Devices Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neurorehabilitation Devices Market Size by Application (2016-2027)
10.4 Middle East & Africa Neurorehabilitation Devices Market Size by Country
10.4.1 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neurorehabilitation Devices Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Neurorehabilitation Devices Introduction
11.1.4 Medtronic Revenue in Neurorehabilitation Devices Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Details
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Neurorehabilitation Devices Introduction
11.2.4 Abbott Laboratories Revenue in Neurorehabilitation Devices Business (2016-2021)
11.2.5 Abbott Laboratories Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Neurorehabilitation Devices Introduction
11.3.4 Boston Scientific Revenue in Neurorehabilitation Devices Business (2016-2021)
11.3.5 Boston Scientific Recent Development
11.4 Bioness
11.4.1 Bioness Company Details
11.4.2 Bioness Business Overview
11.4.3 Bioness Neurorehabilitation Devices Introduction
11.4.4 Bioness Revenue in Neurorehabilitation Devices Business (2016-2021)
11.4.5 Bioness Recent Development
11.5 Hocoma AG
11.5.1 Hocoma AG Company Details
11.5.2 Hocoma AG Business Overview
11.5.3 Hocoma AG Neurorehabilitation Devices Introduction
11.5.4 Hocoma AG Revenue in Neurorehabilitation Devices Business (2016-2021)
11.5.5 Hocoma AG Recent Development
11.6 Neuronetics
11.6.1 Neuronetics Company Details
11.6.2 Neuronetics Business Overview
11.6.3 Neuronetics Neurorehabilitation Devices Introduction
11.6.4 Neuronetics Revenue in Neurorehabilitation Devices Business (2016-2021)
11.6.5 Neuronetics Recent Development
11.7 Yiruide
11.7.1 Yiruide Company Details
11.7.2 Yiruide Business Overview
11.7.3 Yiruide Neurorehabilitation Devices Introduction
11.7.4 Yiruide Revenue in Neurorehabilitation Devices Business (2016-2021)
11.7.5 Yiruide Recent Development
11.8 Magstim
11.8.1 Magstim Company Details
11.8.2 Magstim Business Overview
11.8.3 Magstim Neurorehabilitation Devices Introduction
11.8.4 Magstim Revenue in Neurorehabilitation Devices Business (2016-2021)
11.8.5 Magstim Recent Development
11.9 VISHEE
11.9.1 VISHEE Company Details
11.9.2 VISHEE Business Overview
11.9.3 VISHEE Neurorehabilitation Devices Introduction
11.9.4 VISHEE Revenue in Neurorehabilitation Devices Business (2016-2021)
11.9.5 VISHEE Recent Development
11.10 Ekso Bionics
11.10.1 Ekso Bionics Company Details
11.10.2 Ekso Bionics Business Overview
11.10.3 Ekso Bionics Neurorehabilitation Devices Introduction
11.10.4 Ekso Bionics Revenue in Neurorehabilitation Devices Business (2016-2021)
11.10.5 Ekso Bionics Recent Development
11.11 Alter G
11.11.1 Alter G Company Details
11.11.2 Alter G Business Overview
11.11.3 Alter G Neurorehabilitation Devices Introduction
11.11.4 Alter G Revenue in Neurorehabilitation Devices Business (2016-2021)
11.11.5 Alter G Recent Development
11.12 MagVenture
11.12.1 MagVenture Company Details
11.12.2 MagVenture Business Overview
11.12.3 MagVenture Neurorehabilitation Devices Introduction
11.12.4 MagVenture Revenue in Neurorehabilitation Devices Business (2016-2021)
11.12.5 MagVenture Recent Development
11.13 Tyromotion
11.13.1 Tyromotion Company Details
11.13.2 Tyromotion Business Overview
11.13.3 Tyromotion Neurorehabilitation Devices Introduction
11.13.4 Tyromotion Revenue in Neurorehabilitation Devices Business (2016-2021)
11.13.5 Tyromotion Recent Development
11.14 Soterix Medical
11.14.1 Soterix Medical Company Details
11.14.2 Soterix Medical Business Overview
11.14.3 Soterix Medical Neurorehabilitation Devices Introduction
11.14.4 Soterix Medical Revenue in Neurorehabilitation Devices Business (2016-2021)
11.14.5 Soterix Medical Recent Development
11.15 Neuroelectrics
11.15.1 Neuroelectrics Company Details
11.15.2 Neuroelectrics Business Overview
11.15.3 Neuroelectrics Neurorehabilitation Devices Introduction
11.15.4 Neuroelectrics Revenue in Neurorehabilitation Devices Business (2016-2021)
11.15.5 Neuroelectrics Recent Development
11.16 Bionik Laboratories
11.16.1 Bionik Laboratories Company Details
11.16.2 Bionik Laboratories Business Overview
11.16.3 Bionik Laboratories Neurorehabilitation Devices Introduction
11.16.4 Bionik Laboratories Revenue in Neurorehabilitation Devices Business (2016-2021)
11.16.5 Bionik Laboratories Recent Development
11.17 Helius Medical
11.17.1 Helius Medical Company Details
11.17.2 Helius Medical Business Overview
11.17.3 Helius Medical Neurorehabilitation Devices Introduction
11.17.4 Helius Medical Revenue in Neurorehabilitation Devices Business (2016-2021)
11.17.5 Helius Medical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neurorehabilitation Devices Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Implantable Neurorehabilitation System
Table 3. Key Players of Neurorobotic System
Table 4. Key Players of Brain Computer Interface
Table 5. Key Players of Non-invasive Stimulators
Table 6. Key Players of Other
Table 7. Global Neurorehabilitation Devices Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Neurorehabilitation Devices Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Neurorehabilitation Devices Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Neurorehabilitation Devices Market Share by Regions (2016-2021)
Table 11. Global Neurorehabilitation Devices Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Neurorehabilitation Devices Market Share by Regions (2022-2027)
Table 13. Neurorehabilitation Devices Market Trends
Table 14. Neurorehabilitation Devices Market Drivers
Table 15. Neurorehabilitation Devices Market Challenges
Table 16. Neurorehabilitation Devices Market Restraints
Table 17. Global Neurorehabilitation Devices Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Neurorehabilitation Devices Market Share by Players (2016-2021)
Table 19. Global Top Neurorehabilitation Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurorehabilitation Devices as of 2020)
Table 20. Ranking of Global Top Neurorehabilitation Devices Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Neurorehabilitation Devices Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neurorehabilitation Devices Product Solution and Service
Table 24. Date of Enter into Neurorehabilitation Devices Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neurorehabilitation Devices Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Neurorehabilitation Devices Revenue Market Share by Type (2016-2021)
Table 28. Global Neurorehabilitation Devices Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Neurorehabilitation Devices Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Neurorehabilitation Devices Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Neurorehabilitation Devices Revenue Market Share by Application (2016-2021)
Table 32. Global Neurorehabilitation Devices Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Neurorehabilitation Devices Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Neurorehabilitation Devices Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Neurorehabilitation Devices Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Neurorehabilitation Devices Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Neurorehabilitation Devices Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Neurorehabilitation Devices Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Neurorehabilitation Devices Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Neurorehabilitation Devices Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Neurorehabilitation Devices Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Neurorehabilitation Devices Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Neurorehabilitation Devices Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Neurorehabilitation Devices Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Neurorehabilitation Devices Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Neurorehabilitation Devices Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Neurorehabilitation Devices Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neurorehabilitation Devices Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Neurorehabilitation Devices Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Neurorehabilitation Devices Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Neurorehabilitation Devices Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Neurorehabilitation Devices Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Neurorehabilitation Devices Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Neurorehabilitation Devices Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Neurorehabilitation Devices Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Neurorehabilitation Devices Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Neurorehabilitation Devices Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Neurorehabilitation Devices Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Neurorehabilitation Devices Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neurorehabilitation Devices Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Neurorehabilitation Devices Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Neurorehabilitation Devices Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Neurorehabilitation Devices Market Size by Country (2022-2027) & (US$ Million)
Table 64. Medtronic Company Details
Table 65. Medtronic Business Overview
Table 66. Medtronic Neurorehabilitation Devices Product
Table 67. Medtronic Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 68. Medtronic Recent Development
Table 69. Abbott Laboratories Company Details
Table 70. Abbott Laboratories Business Overview
Table 71. Abbott Laboratories Neurorehabilitation Devices Product
Table 72. Abbott Laboratories Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 73. Abbott Laboratories Recent Development
Table 74. Boston Scientific Company Details
Table 75. Boston Scientific Business Overview
Table 76. Boston Scientific Neurorehabilitation Devices Product
Table 77. Boston Scientific Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 78. Boston Scientific Recent Development
Table 79. Bioness Company Details
Table 80. Bioness Business Overview
Table 81. Bioness Neurorehabilitation Devices Product
Table 82. Bioness Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 83. Bioness Recent Development
Table 84. Hocoma AG Company Details
Table 85. Hocoma AG Business Overview
Table 86. Hocoma AG Neurorehabilitation Devices Product
Table 87. Hocoma AG Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 88. Hocoma AG Recent Development
Table 89. Neuronetics Company Details
Table 90. Neuronetics Business Overview
Table 91. Neuronetics Neurorehabilitation Devices Product
Table 92. Neuronetics Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 93. Neuronetics Recent Development
Table 94. Yiruide Company Details
Table 95. Yiruide Business Overview
Table 96. Yiruide Neurorehabilitation Devices Product
Table 97. Yiruide Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 98. Yiruide Recent Development
Table 99. Magstim Company Details
Table 100. Magstim Business Overview
Table 101. Magstim Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 102. Magstim Recent Development
Table 103. VISHEE Company Details
Table 104. VISHEE Business Overview
Table 105. VISHEE Neurorehabilitation Devices Product
Table 106. VISHEE Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 107. VISHEE Recent Development
Table 108. Ekso Bionics Company Details
Table 109. Ekso Bionics Business Overview
Table 110. Ekso Bionics Neurorehabilitation Devices Product
Table 111. Ekso Bionics Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 112. Ekso Bionics Recent Development
Table 113. Alter G Company Details
Table 114. Alter G Business Overview
Table 115. Alter G Neurorehabilitation Devices Product
Table 116. Alter G Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 117. Alter G Recent Development
Table 118. MagVenture Company Details
Table 119. MagVenture Business Overview
Table 120. MagVenture Neurorehabilitation Devices Product
Table 121. MagVenture Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 122. MagVenture Recent Development
Table 123. Tyromotion Company Details
Table 124. Tyromotion Business Overview
Table 125. Tyromotion Neurorehabilitation Devices Product
Table 126. Tyromotion Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 127. Tyromotion Recent Development
Table 128. Soterix Medical Company Details
Table 129. Soterix Medical Business Overview
Table 130. Soterix Medical Neurorehabilitation Devices Product
Table 131. Soterix Medical Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 132. Soterix Medical Recent Development
Table 133. Neuroelectrics Company Details
Table 134. Neuroelectrics Business Overview
Table 135. Neuroelectrics Neurorehabilitation Devices Product
Table 136. Neuroelectrics Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 137. Neuroelectrics Recent Development
Table 138. Bionik Laboratories Company Details
Table 139. Bionik Laboratories Business Overview
Table 140. Bionik Laboratories Neurorehabilitation Devices Product
Table 141. Bionik Laboratories Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 142. Bionik Laboratories Recent Development
Table 143. Helius Medical Company Details
Table 144. Helius Medical Business Overview
Table 145. Helius Medical Neurorehabilitation Devices Product
Table 146. Helius Medical Revenue in Neurorehabilitation Devices Business (2016-2021) & (US$ Million)
Table 147. Helius Medical Recent Development
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurorehabilitation Devices Market Share by Type: 2020 VS 2027
Figure 2. Implantable Neurorehabilitation System Features
Figure 3. Neurorobotic System Features
Figure 4. Brain Computer Interface Features
Figure 5. Non-invasive Stimulators Features
Figure 6. Other Features
Figure 7. Global Neurorehabilitation Devices Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Neurorehabilitation Devices Report Years Considered
Figure 12. Global Neurorehabilitation Devices Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Neurorehabilitation Devices Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Neurorehabilitation Devices Market Share by Regions: 2020 VS 2027
Figure 15. Global Neurorehabilitation Devices Market Share by Regions (2022-2027)
Figure 16. Global Neurorehabilitation Devices Market Share by Players in 2020
Figure 17. Global Top Neurorehabilitation Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurorehabilitation Devices as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Neurorehabilitation Devices Revenue in 2020
Figure 19. Global Neurorehabilitation Devices Revenue Market Share by Type (2016-2021)
Figure 20. Global Neurorehabilitation Devices Revenue Market Share by Type (2022-2027)
Figure 21. North America Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Neurorehabilitation Devices Market Share by Type (2016-2027)
Figure 23. North America Neurorehabilitation Devices Market Share by Application (2016-2027)
Figure 24. North America Neurorehabilitation Devices Market Share by Country (2016-2027)
Figure 25. United States Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Neurorehabilitation Devices Market Share by Type (2016-2027)
Figure 29. Europe Neurorehabilitation Devices Market Share by Application (2016-2027)
Figure 30. Europe Neurorehabilitation Devices Market Share by Country (2016-2027)
Figure 31. Germany Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Neurorehabilitation Devices Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Neurorehabilitation Devices Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Neurorehabilitation Devices Market Share by Region (2016-2027)
Figure 41. China Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Neurorehabilitation Devices Market Share by Type (2016-2027)
Figure 49. Latin America Neurorehabilitation Devices Market Share by Application (2016-2027)
Figure 50. Latin America Neurorehabilitation Devices Market Share by Country (2016-2027)
Figure 51. Mexico Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Neurorehabilitation Devices Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Neurorehabilitation Devices Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Neurorehabilitation Devices Market Share by Country (2016-2027)
Figure 57. Turkey Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Neurorehabilitation Devices Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Medtronic Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 61. Abbott Laboratories Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 62. Boston Scientific Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 63. Bioness Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 64. Hocoma AG Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 65. Neuronetics Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 66. Yiruide Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 67. Magstim Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 68. VISHEE Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 69. Ekso Bionics Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 70. Alter G Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 71. MagVenture Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 72. Tyromotion Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 73. Soterix Medical Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 74. Neuroelectrics Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 75. Bionik Laboratories Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 76. Helius Medical Revenue Growth Rate in Neurorehabilitation Devices Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed